Results 1 to 10 of about 459,727 (225)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage. [PDF]

Front Cell Infect Microbiol, 2023
Neisseria meningitidis causes invasive meningococcal disease (IMD), which is associated with significant mortality and long-term consequences, especially among young children.
Sereikaitė E, Plepytė R, Petrutienė A, Stravinskienė D, Kučinskaitė-Kodzė I, Gėgžna V, Ivaškevičienė I, Žvirblienė A, Plečkaitytė M.   +8 more
europepmc   +2 more sources

Current status and challenges of meningococcal vaccines development in China

Zhongguo gonggong weisheng, 2022
Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj   +1 more source

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)

Эпидемиология и вакцинопрофилактика, 2022
Relevance. The success of vaccine prophylaxis of meningococcal infection depends on the composition and properties of vaccine preparations and the strict implementation of recommendations on vaccine prophylaxis tactics by the territorial epidemiological ...
I. S. Koroleva, M. A. Koroleva
doaj   +1 more source

Barriers and facilitators to HPV and meningococcal vaccination among men who have sex with men: a qualitative study

BMC Public Health, 2023
Background Men who have sex with men (MSM) have suboptimal uptake of human papillomavirus (HPV) and meningococcal vaccines. This study examines barriers and facilitators to HPV and meningococcal vaccination among MSM in a large, racially/ethnically ...
Justin Naidu, Andrea N. Polonijo
doaj   +1 more source

Effectiveness of meningococcal C conjugate vaccine in Salvador, Brazil: a case-control study. [PDF]

PLoS ONE, 2015
BACKGROUND:During a citywide epidemic of serogroup C meningococcal disease in Salvador in 2010, Brazil, the state government initiated mass vaccination targeting two age groups with high attack rates: individuals aged
Cristiane Wanderley Cardoso, Guilherme Sousa Ribeiro, Mitermayer Galvão Reis, Brendan Flannery, Joice Neves Reis   +4 more
doaj   +1 more source

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities

Вопросы современной педиатрии, 2017
Meningococcal infection is an acute disease caused by Neisseria meningitidis, which proceeds with a diverse clinical aspect from nasopharyngitis to meningococcal meningitis and meningococcemia.
Leyla S. Namazova-Baranova, Daria A. Novikova, Marina V. Fedoseenko, Anna G. Gaivoronskaya, Natalia E. Tkachenko, Tatiana A. Kaljuzhnaya, Firuza Ch. Shakhtakhtinskaya, Marika I. Broeva   +7 more
doaj   +1 more source

Recommendations for the use of meningococcal vaccines in South Africa

Southern African Journal of Infectious Diseases, 2017
Background: Although meningococcal disease (MD) incidence in South Africa is low, Neisseria meningitidis (NM) causes severe disease that is often life-threatening and can cause long-term disabilities.
Susan Meiring, Gregory Hussey, Prakash Jeena, Salim Parker, Anne von Gottberg   +4 more
doaj   +1 more source

Analysis of novel meningococcal vaccine formulations

Human Vaccines & Immunotherapeutics, 2017
The protective effect of meningococcal vaccines targeting disease causing serogroups exemplified by the introduction of MenAfriVac™ in Africa, is well established and documented in large population-based studies.
Susu M. Zughaier
doaj   +1 more source

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil

Brazilian Journal of Infectious Diseases, 2014
Objectives: To analyze the behavior of meningococcal disease in the Federal District, Brazil, from 2005 to 2011, and to assess the direct impact of the meningococcal serogroup C conjugate vaccine.
Márcia de Cantuária Tauil, Cleidiane Santos Rodrigues de Carvalho, Ataiza César Vieira, Eliseu Alves Waldman   +3 more
doaj   +1 more source

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age

Human Vaccines & Immunotherapeutics, 2022
Vaccination offers the best way to prevent invasive meningococcal disease (IMD). As demonstrated in countries with national immunization programs (NIPs) against IMD, meningococcal conjugate vaccines have contributed to significant declines in incidence ...
Gary S. Marshall, Stephen I. Pelton, Corwin A. Robertson, Philipp Oster   +3 more
doaj   +1 more source